Absolute 0 8 0 8 B-clinical_variable
neutrophil 9 19 9 19 I-clinical_variable
count 20 25 20 25 I-clinical_variable
( 26 27 26 27 I-clinical_variable
ANC 27 30 27 30 I-clinical_variable
) 30 31 30 31 I-clinical_variable
≥ 32 33 32 33 O
1500 34 38 34 38 B-lower_bound
/ 38 39 38 39 I-lower_bound
mm3 39 42 39 42 I-lower_bound
without 43 50 43 50 O
colony 51 57 51 57 B-treatment
stimulating 58 69 58 69 I-treatment
factor 70 76 70 76 I-treatment
support 77 84 77 84 O

Alanine 0 7 85 92 B-clinical_variable
aminotransferase 8 24 93 109 I-clinical_variable
( 25 26 110 111 I-clinical_variable
ALT 26 29 111 114 I-clinical_variable
) 29 30 114 115 I-clinical_variable
and 31 34 116 119 O
aspartate 35 44 120 129 B-clinical_variable
aminotransferase 45 61 130 146 I-clinical_variable
( 62 63 147 148 I-clinical_variable
AST 63 66 148 151 I-clinical_variable
) 66 67 151 152 I-clinical_variable

Any 0 3 153 156 O
congenital 4 14 157 167 O
history 15 22 168 175 O
of 23 25 176 178 O
long 26 30 179 183 O
QT 31 33 184 186 B-chronic_disease
syndrome 34 42 187 195 I-chronic_disease

Any 0 3 196 199 O
type 4 8 200 204 O
of 9 11 205 207 O
systemic 12 20 208 216 B-treatment
anticancer 21 31 217 227 I-treatment
agent 32 37 228 233 I-treatment
( 38 39 234 235 O
including 39 48 235 244 O
investigational 49 64 245 260 O
) 64 65 260 261 O
within 66 72 262 268 O
3 73 74 269 270 B-upper_bound
weeks 75 80 271 276 I-upper_bound
of 81 83 277 279 O
first 84 89 280 285 O
dose 90 94 286 290 O
of 95 97 291 293 O
study 98 103 294 299 B-treatment
treatment 104 113 300 309 I-treatment
, 113 114 309 310 O
or 115 117 311 313 O
within 118 124 314 320 O
5 125 126 321 322 B-upper_bound
half 127 131 323 327 I-upper_bound
- 131 132 327 328 I-upper_bound
lives 132 137 328 333 I-upper_bound
of 138 140 334 336 O
the 141 144 337 340 O
agent 145 150 341 346 O
whichever 151 160 347 356 O
is 161 163 357 359 O
shorter 164 171 360 367 O
. 171 172 367 368 O
Subjects 173 181 369 377 O
on 182 184 378 380 O
LHRH 185 189 381 385 B-treatment
or 190 192 386 388 O
GnRH 193 197 389 393 B-treatment
agonists 198 206 394 402 I-treatment
may 207 210 403 406 O
be 211 213 407 409 O
maintained 214 224 410 420 O
on 225 227 421 423 O
these 228 233 424 429 O
agents 234 240 430 436 O

Bilirubin 0 9 437 446 B-clinical_variable
≤ 10 11 447 448 O
1.5 12 15 449 452 B-upper_bound
× 16 17 453 454 I-upper_bound
the 18 21 455 458 I-upper_bound
upper 22 27 459 464 I-upper_bound
limit 28 33 465 470 I-upper_bound
of 34 36 471 473 I-upper_bound
normal 37 43 474 480 I-upper_bound
( 44 45 481 482 I-upper_bound
ULN 45 48 482 485 I-upper_bound
) 48 49 485 486 I-upper_bound
. 49 50 486 487 O
For 51 54 488 491 O
subjects 55 63 492 500 O
with 64 68 501 505 O
known 69 74 506 511 O
Gilbert 75 82 512 519 B-chronic_disease
's 82 84 519 521 I-chronic_disease
. 85 86 522 523 I-chronic_disease
disease 87 94 524 531 I-chronic_disease
, 94 95 531 532 O
bilirubin 96 105 533 542 B-clinical_variable
≤ 106 107 543 544 O
3.0 108 111 545 548 B-upper_bound
mg 112 114 549 551 I-upper_bound
/ 114 115 551 552 I-upper_bound
dL 115 117 552 554 I-upper_bound

Cardiovascular 0 14 555 569 B-chronic_disease
disorders 15 24 570 579 I-chronic_disease
including 25 34 580 589 O
Congestive 35 45 590 600 B-chronic_disease
heart 46 51 601 606 I-chronic_disease
failure 52 59 607 614 I-chronic_disease
( 60 61 615 616 I-chronic_disease
CHF 61 64 616 619 I-chronic_disease
): 64 66 619 621 I-chronic_disease
New 67 70 622 625 B-clinical_variable
York 71 75 626 630 I-clinical_variable
Heart 76 81 631 636 I-clinical_variable
Association 82 93 637 648 I-clinical_variable
( 94 95 649 650 I-clinical_variable
NYHA 95 99 650 654 I-clinical_variable
) 99 100 654 655 I-clinical_variable
Class 101 106 656 661 B-lower_bound
III 107 110 662 665 I-lower_bound
( 111 112 666 667 I-lower_bound
moderate 112 120 667 675 I-lower_bound
) 120 121 675 676 I-lower_bound
or 122 124 677 679 O
Class 125 130 680 685 B-upper_bound
IV 131 133 686 688 I-upper_bound
( 134 135 689 690 I-upper_bound
severe 135 141 690 696 I-upper_bound
) 141 142 696 697 I-upper_bound
at 143 145 698 700 O
the 146 149 701 704 O
time 150 154 705 709 O
of 155 157 710 712 O
screening 158 167 713 722 O

Clinically 0 10 723 733 O
- 10 11 733 734 O
significant 11 22 734 745 O
hemoptysis 23 33 746 756 B-clinical_variable
of 34 36 757 759 O
≥ 37 38 760 761 O
0.5 39 42 762 765 B-lower_bound
teaspoon 43 51 766 774 I-lower_bound
( 52 53 775 776 O
2.5ml 53 58 776 781 O
) 58 59 781 782 O
of 60 62 783 785 O
red 63 66 786 789 O
blood 67 72 790 795 O
c. 73 75 796 798 O
any 76 79 799 802 O
other 80 85 803 808 O
signs 86 91 809 814 O
indicative 92 102 815 825 O
of 103 105 826 828 O
pulmonary 106 115 829 838 O
hemorrhage 116 126 839 849 O

Concurrent 0 10 850 860 O
uncontrolled 11 23 861 873 O
hypertension 24 36 874 886 B-chronic_disease
defined 37 44 887 894 O
as 45 47 895 897 O
sustained 48 57 898 907 O
BP 58 60 908 910 B-clinical_variable
≥ 61 62 911 912 O
150 63 66 913 916 B-lower_bound
mm 67 69 917 919 I-lower_bound
Hg 70 72 920 922 I-lower_bound
systolic 73 81 923 931 B-clinical_variable
, 81 82 931 932 O
or 83 85 933 935 O
≥ 86 87 936 937 O
90 88 90 938 940 B-lower_bound
mm 91 93 941 943 I-lower_bound
Hg 94 96 944 946 I-lower_bound
diastolic 97 106 947 956 B-clinical_variable
despite 107 114 957 964 O
optimal 115 122 965 972 B-treatment
antihypertensive 123 139 973 989 I-treatment
treatment 140 149 990 999 I-treatment

CrCl 0 4 1000 1004 B-clinical_variable
( 5 6 1005 1006 O
mL 6 8 1006 1008 O
/ 8 9 1008 1009 O
min 9 12 1009 1012 O
) 12 13 1012 1013 O
= 14 15 1014 1015 O
( 16 17 1016 1017 O
140 17 20 1017 1020 O
- 21 22 1021 1022 O
age 23 26 1023 1026 B-age
) 26 27 1026 1027 O
× 28 29 1028 1029 O
wt 30 32 1030 1032 B-clinical_variable
( 33 34 1033 1034 O
kg 34 36 1034 1036 O
) 36 37 1036 1037 O
/ 38 39 1038 1039 O
( 40 41 1040 1041 O
serum 41 46 1041 1046 B-clinical_variable
creatinine 47 57 1047 1057 I-clinical_variable
× 58 59 1058 1059 O
72 60 62 1060 1062 O
) 62 63 1062 1063 O

Female 0 6 1064 1070 B-gender

Gastrointestinal 0 16 1071 1087 B-chronic_disease
disorders 17 26 1088 1097 I-chronic_disease
particularly 27 39 1098 1110 O
those 40 45 1111 1116 O
associated 46 56 1117 1127 O
with 57 61 1128 1132 O
a 62 63 1133 1134 O
high 64 68 1135 1139 O
risk 69 73 1140 1144 O
of 74 76 1145 1147 O
perforation 77 88 1148 1159 O
or 89 91 1160 1162 O
fistula 92 99 1163 1170 B-chronic_disease
formation 100 109 1171 1180 O

Group 0 5 1181 1186 O
A 6 7 1187 1188 O
: 7 8 1188 1189 O
KIF5B 9 14 1190 1195 B-clinical_variable
/ 14 15 1195 1196 I-clinical_variable
RET 15 18 1196 1199 I-clinical_variable
or 19 21 1200 1202 O
related 22 29 1203 1210 O
variant 30 37 1211 1218 O
RET 38 41 1219 1222 O
fusions 42 49 1223 1230 O

Major 0 5 1231 1236 B-treatment
surgery 6 13 1237 1244 I-treatment
( 14 15 1245 1246 O
eg 15 17 1246 1248 O
, 17 18 1248 1249 O
thoracotomy 19 30 1250 1261 B-treatment
, 30 31 1261 1262 O
removal 32 39 1263 1270 B-treatment
or 40 42 1271 1273 I-treatment
biopsy 43 49 1274 1280 I-treatment
of 50 52 1281 1283 I-treatment
brain 53 58 1284 1289 I-treatment
metastasis 59 69 1290 1300 I-treatment
) 69 70 1300 1301 O
within 71 77 1302 1308 O
3 78 79 1309 1310 B-upper_bound
months 80 86 1311 1317 I-upper_bound
before 87 93 1318 1324 O
Week 94 98 1325 1329 O
1 99 100 1330 1331 O
Day 101 104 1332 1335 O
1 105 106 1336 1337 O
. 106 107 1337 1338 O
Complete 108 116 1339 1347 O
wound 117 122 1348 1353 O
healing 123 130 1354 1361 O
from 131 135 1362 1366 O
major 136 141 1367 1372 B-treatment
surgery 142 149 1373 1380 I-treatment
must 150 154 1381 1385 O
have 155 159 1386 1390 O
occurred 160 168 1391 1399 O
1 169 170 1400 1401 B-upper_bound
month 171 176 1402 1407 I-upper_bound
before 177 183 1408 1414 I-upper_bound
Week 184 188 1415 1419 O
1 189 190 1420 1421 O
Day 191 194 1422 1425 O
1 195 196 1426 1427 O
and 197 200 1428 1431 O
from 201 205 1432 1436 O
minor 206 211 1437 1442 B-treatment
surgery 212 219 1443 1450 I-treatment
( 220 221 1451 1452 O
eg 221 223 1452 1454 O
, 223 224 1454 1455 O
simple 225 231 1456 1462 B-treatment
excision 232 240 1463 1471 I-treatment
, 240 241 1471 1472 O
tooth 242 247 1473 1478 B-treatment
extraction 248 258 1479 1489 I-treatment
) 258 259 1489 1490 O
at 260 262 1491 1493 O
least 263 268 1494 1499 O
10 269 271 1500 1502 B-lower_bound
days 272 276 1503 1507 I-lower_bound
before 277 283 1508 1514 I-lower_bound
Week 284 288 1515 1519 O
1 289 290 1520 1521 O
Day 291 294 1522 1525 O
1 295 296 1526 1527 O
. 296 297 1527 1528 O
Subjects 298 306 1529 1537 O
with 307 311 1538 1542 O
clinically 312 322 1543 1553 O
relevant 323 331 1554 1562 O
ongoing 332 339 1563 1570 O
complications 340 353 1571 1584 O
from 354 358 1585 1589 O
prior 359 364 1590 1595 B-treatment
surgery 365 372 1596 1603 I-treatment
are 373 376 1604 1607 O
not 377 380 1608 1611 O
eligible 381 389 1612 1620 O

Male 0 4 1621 1625 B-gender

Other 0 5 1626 1631 O
disorders 6 15 1632 1641 O
associated 16 26 1642 1652 O
with 27 31 1653 1657 O
a 32 33 1658 1659 O
high 34 38 1660 1664 O
risk 39 43 1665 1669 O
of 44 46 1670 1672 O
fistula 47 54 1673 1680 B-chronic_disease
formation 55 64 1681 1690 O
including 65 74 1691 1700 O
PEG 75 78 1701 1704 B-treatment
tube 79 83 1705 1709 I-treatment
placement 84 93 1710 1719 I-treatment
within 94 100 1720 1726 O
3 101 102 1727 1728 B-upper_bound
months 103 109 1729 1735 I-upper_bound
before 110 116 1736 1742 I-upper_bound
the 117 120 1743 1746 O
first 121 126 1747 1752 O
dose 127 131 1753 1757 O
of 132 134 1758 1760 O
study 135 140 1761 1766 B-treatment
therapy 141 148 1767 1774 I-treatment
or 149 151 1775 1777 O
concurrent 152 162 1778 1788 O
evidence 163 171 1789 1797 O
of 172 174 1798 1800 O
intraluminal 175 187 1801 1813 B-cancer
tumor 188 193 1814 1819 I-cancer
involving 194 203 1820 1829 O
the 204 207 1830 1833 O
trachea 208 215 1834 1841 O
and 216 219 1842 1845 O
esophagus 220 229 1846 1855 O

Platelets 0 9 1856 1865 B-clinical_variable
≥ 10 11 1866 1867 O
100,000 12 19 1868 1875 B-lower_bound
/ 19 20 1875 1876 I-lower_bound
mm3 20 23 1876 1879 I-lower_bound
Hemoglobin 24 34 1880 1890 B-clinical_variable
≥ 35 36 1891 1892 O
9 37 38 1893 1894 B-lower_bound
g 39 40 1895 1896 I-lower_bound
/ 40 41 1896 1897 I-lower_bound
dL 41 43 1897 1899 I-lower_bound

Postmenopause 0 13 1900 1913 O
is 14 16 1914 1916 O
defined 17 24 1917 1924 O
as 25 27 1925 1927 O
amenorrhea 28 38 1928 1938 B-clinical_variable
≥ 39 40 1939 1940 O
12 41 43 1941 1943 B-lower_bound
consecutive 44 55 1944 1955 I-lower_bound
months 56 62 1956 1962 I-lower_bound

Prior 0 5 1963 1968 B-treatment
treatment 6 15 1969 1978 I-treatment
with 16 20 1979 1983 I-treatment
cabozantinib 21 33 1984 1996 I-treatment

ROS1 0 4 1997 2001 B-treatment
infustion 5 14 2002 2011 I-treatment

Radiation 0 9 2012 2021 B-treatment
therapy 10 17 2022 2029 I-treatment
for 18 21 2030 2033 O
bone 22 26 2034 2038 B-cancer
or 27 29 2039 2041 O
brain 30 35 2042 2047 B-cancer
metastasis 36 46 2048 2058 I-cancer
within 47 53 2059 2065 O
2 54 55 2066 2067 B-upper_bound
weeks 56 61 2068 2073 I-upper_bound
, 61 62 2073 2074 O
any 63 66 2075 2078 O
other 67 72 2079 2084 O
external 73 81 2085 2093 B-treatment
radiation 82 91 2094 2103 I-treatment
therapy 92 99 2104 2111 I-treatment
within 100 106 2112 2118 O
4 107 108 2119 2120 B-upper_bound
weeks 109 114 2121 2126 I-upper_bound
of 115 117 2127 2129 O
first 118 123 2130 2135 O
dose 124 128 2136 2140 O
of 129 131 2141 2143 O
study 132 137 2144 2149 O
drug 138 142 2150 2154 O
. 142 143 2154 2155 O
Systemic 144 152 2156 2164 B-treatment
treatment 153 162 2165 2174 I-treatment
with 163 167 2175 2179 I-treatment
radionuclides 168 181 2180 2193 I-treatment
within 182 188 2194 2200 O
4weeks 189 195 2201 2207 B-upper_bound
. 195 196 2207 2208 O
Subjects 197 205 2209 2217 O
with 206 210 2218 2222 O
clinically 211 221 2223 2233 O
relevant 222 230 2234 2242 O
ongoing 231 238 2243 2250 O
complications 239 252 2251 2264 O
from 253 257 2265 2269 O
prior 258 263 2270 2275 B-treatment
radiation 264 273 2276 2285 I-treatment
therapy 274 281 2286 2293 I-treatment
are 282 285 2294 2297 O
not 286 289 2298 2301 O
eligible 290 298 2302 2310 O

Serum 0 5 2311 2316 B-clinical_variable
creatinine 6 16 2317 2327 I-clinical_variable
≤ 17 18 2328 2329 O
1.5 19 22 2330 2333 B-upper_bound
× 23 24 2334 2335 I-upper_bound
ULN 25 28 2336 2339 I-upper_bound
or 29 31 2340 2342 O
creatinine 32 42 2343 2353 B-clinical_variable
clearance 43 52 2354 2363 I-clinical_variable
( 53 54 2364 2365 I-clinical_variable
CrCl 54 58 2365 2369 I-clinical_variable
) 58 59 2369 2370 I-clinical_variable
≥ 60 61 2371 2372 O
30 62 64 2373 2375 B-lower_bound
mL 65 67 2376 2378 I-lower_bound
/ 67 68 2378 2379 I-lower_bound
min 68 71 2379 2382 I-lower_bound
. 71 72 2382 2383 O
For 73 76 2384 2387 O
creatinine 77 87 2388 2398 B-clinical_variable
clearance 88 97 2399 2408 I-clinical_variable
estimation 98 108 2409 2419 I-clinical_variable
, 108 109 2419 2420 O
the 110 113 2421 2424 O
Cockcroft 114 123 2425 2434 B-clinical_variable
and 124 127 2435 2438 I-clinical_variable
Gault 128 133 2439 2444 I-clinical_variable
equation 134 142 2445 2453 I-clinical_variable
should 143 149 2454 2460 O
be 150 152 2461 2463 O
used 153 157 2464 2468 O

Serum 0 5 2469 2474 B-clinical_variable
phosphorus 6 16 2475 2485 I-clinical_variable
, 16 17 2485 2486 O
magnesium 18 27 2487 2496 B-clinical_variable
, 27 28 2496 2497 O
and 29 32 2498 2501 O
potassium 33 42 2502 2511 B-clinical_variable
≥ 43 44 2512 2513 O
LLN 45 48 2514 2517 B-clinical_variable
after 49 54 2518 2523 O
adequate 55 63 2524 2532 O
supplementation 64 79 2533 2548 O
if 80 82 2549 2551 O
necessary 83 92 2552 2561 O

The 0 3 2562 2565 O
subject 4 11 2566 2573 O
has 12 15 2574 2577 O
a 16 17 2578 2579 O
Karnofsky 18 27 2580 2589 B-clinical_variable
performance 28 39 2590 2601 I-clinical_variable
status 40 46 2602 2608 I-clinical_variable
of 47 49 2609 2611 O
> 50 51 2612 2613 O
70 52 54 2614 2616 B-lower_bound
% 54 55 2616 2617 I-lower_bound

The 0 3 2618 2621 O
subject 4 11 2622 2629 O
has 12 15 2630 2633 O
a 16 17 2634 2635 O
corrected 18 27 2636 2645 O
QT 28 30 2646 2648 B-clinical_variable
interval 31 39 2649 2657 I-clinical_variable
calculated 40 50 2658 2668 I-clinical_variable
by 51 53 2669 2671 I-clinical_variable
the 54 57 2672 2675 I-clinical_variable
Fridericia 58 68 2676 2686 I-clinical_variable
formula 69 76 2687 2694 I-clinical_variable
( 77 78 2695 2696 I-clinical_variable
QTcF 78 82 2696 2700 I-clinical_variable
) 82 83 2700 2701 I-clinical_variable
> 84 85 2702 2703 O
500 86 89 2704 2707 B-lower_bound
ms 90 92 2708 2710 I-lower_bound
14 93 95 2711 2713 B-upper_bound
days 96 100 2714 2718 I-upper_bound
before 101 107 2719 2725 O
Week 108 112 2726 2730 O
1 113 114 2731 2732 O
Day 115 118 2733 2736 O
1 119 120 2737 2738 O

The 0 3 2739 2742 O
subject 4 11 2743 2750 O
has 12 15 2751 2754 O
a 16 17 2755 2756 O
pathologic 18 28 2757 2767 O
diagnosis 29 38 2768 2777 O
of 39 41 2778 2780 O
non 42 45 2781 2784 B-cancer
- 45 46 2784 2785 I-cancer
small 46 51 2785 2790 I-cancer
cell 52 56 2791 2795 I-cancer
lung 57 61 2796 2800 I-cancer
carcinoma 62 71 2801 2810 I-cancer
that 72 76 2811 2815 O
is 77 79 2816 2818 O
metastatic 80 90 2819 2829 O
or 91 93 2830 2832 O
unresectable 94 106 2833 2845 O

The 0 3 2846 2849 O
subject 4 11 2850 2857 O
has 12 15 2858 2861 O
a 16 17 2862 2863 O
previously 18 28 2864 2874 O
identified 29 39 2875 2885 O
allergy 40 47 2886 2893 O
or 48 50 2894 2896 O
hypersensitivity 51 67 2897 2913 O
to 68 70 2914 2916 O
components 71 81 2917 2927 O
of 82 84 2928 2930 O
the 85 88 2931 2934 O
study 89 94 2935 2940 B-treatment
treatment 95 104 2941 2950 I-treatment
formulation 105 116 2951 2962 O

The 0 3 2963 2966 O
subject 4 11 2967 2974 O
has 12 15 2975 2978 O
any 16 19 2979 2982 O
evidence 20 28 2983 2991 O
of 29 31 2992 2994 O
an 32 34 2995 2997 O
endotracheal 35 47 2998 3010 B-cancer
or 48 50 3011 3013 O
endobronchial 51 64 3014 3027 B-cancer
tumor 65 70 3028 3033 I-cancer
within 71 77 3034 3040 O
28 78 80 3041 3043 B-upper_bound
days 81 85 3044 3048 I-upper_bound
before 86 92 3049 3055 O
the 93 96 3056 3059 O
first 97 102 3060 3065 O
dose 103 107 3066 3070 O
of 108 110 3071 3073 O
cabozantinib 111 123 3074 3086 B-treatment

The 0 3 3087 3090 O
subject 4 11 3091 3098 O
has 12 15 3099 3102 O
not 16 19 3103 3106 O
recovered 20 29 3107 3116 O
to 30 32 3117 3119 O
baseline 33 41 3120 3128 O
or 42 44 3129 3131 O
CTCAE 45 50 3132 3137 B-clinical_variable
≤ 51 52 3138 3139 O
Grade 53 58 3140 3145 B-upper_bound
1 59 60 3146 3147 I-upper_bound
from 61 65 3148 3152 O
toxicity 66 74 3153 3161 O
due 75 78 3162 3165 O
to 79 81 3166 3168 O
all 82 85 3169 3172 O
prior 86 91 3173 3178 B-treatment
therapies 92 101 3179 3188 I-treatment
except 102 108 3189 3195 O
alopecia 109 117 3196 3204 B-chronic_disease
and 118 121 3205 3208 O
other 122 127 3209 3214 O
non 128 131 3215 3218 O
- 131 132 3218 3219 O
clinically 132 142 3219 3229 O
significant 143 154 3230 3241 O
AEs 155 158 3242 3245 B-chronic_disease

The 0 3 3246 3249 O
subject 4 11 3250 3257 O
has 12 15 3258 3261 O
radiographic 16 28 3262 3274 O
evidence 29 37 3275 3283 O
of 38 40 3284 3286 O
cavitating 41 51 3287 3297 B-chronic_disease
pulmonary 52 61 3298 3307 I-chronic_disease
lesion(s 62 70 3308 3316 I-chronic_disease
) 70 71 3316 3317 I-chronic_disease

The 0 3 3318 3321 O
subject 4 11 3322 3329 O
has 12 15 3330 3333 O
tumor 16 21 3334 3339 B-cancer
in 22 24 3340 3342 O
contact 25 32 3343 3350 O
with 33 37 3351 3355 O
invading 38 46 3356 3364 O
major 47 52 3365 3370 O
blood 53 58 3371 3376 O
vessels 59 66 3377 3384 O

The 0 3 3385 3388 O
subject 4 11 3389 3396 O
is 12 14 3397 3399 O
capable 15 22 3400 3407 O
of 23 25 3408 3410 O
understanding 26 39 3411 3424 O
and 40 43 3425 3428 O
complying 44 53 3429 3438 O
with 54 58 3439 3443 O
the 59 62 3444 3447 O
protocol 63 71 3448 3456 O
requirements 72 84 3457 3469 O
and 85 88 3470 3473 O
has 89 92 3474 3477 O
signed 93 99 3478 3484 O
the 100 103 3485 3488 O
informed 104 112 3489 3497 O
consent 113 120 3498 3505 O
document 121 129 3506 3514 O
. 129 130 3514 3515 O
Sexually 131 139 3516 3524 O
active 140 146 3525 3531 O
subjects 147 155 3532 3540 O
( 156 157 3541 3542 O
men 157 160 3542 3545 B-gender
and 161 164 3546 3549 I-gender
women 165 170 3550 3555 I-gender
) 170 171 3555 3556 O
must 172 176 3557 3561 O
agree 177 182 3562 3567 B-contraception_consent
to 183 185 3568 3570 I-contraception_consent
use 186 189 3571 3574 I-contraception_consent
medically 190 199 3575 3584 I-contraception_consent
accepted 200 208 3585 3593 I-contraception_consent
barrier 209 216 3594 3601 I-contraception_consent
methods 217 224 3602 3609 I-contraception_consent
of 225 227 3610 3612 I-contraception_consent
contraception 228 241 3613 3626 I-contraception_consent
( 242 243 3627 3628 O
eg 243 245 3628 3630 O
, 245 246 3630 3631 O
male 247 251 3632 3636 B-gender
or 252 254 3637 3639 I-gender
female 255 261 3640 3646 I-gender
condom 262 268 3647 3653 B-contraception_consent
) 268 269 3653 3654 O
during 270 276 3655 3661 O
the 277 280 3662 3665 O
course 281 287 3666 3672 O
of 288 290 3673 3675 O
the 291 294 3676 3679 O
study 295 300 3680 3685 O
and 301 304 3686 3689 O
for 305 308 3690 3693 O
4 309 310 3694 3695 B-upper_bound
months 311 317 3696 3702 I-upper_bound
after 318 323 3703 3708 O
the 324 327 3709 3712 O
last 328 332 3713 3717 O
dose 333 337 3718 3722 O
of 338 340 3723 3725 O
study 341 346 3726 3731 B-treatment
drug(s 347 353 3732 3738 I-treatment
) 353 354 3738 3739 I-treatment
, 354 355 3739 3740 O
even 356 360 3741 3745 O
if 361 363 3746 3748 O
oral 364 368 3749 3753 B-contraception_consent
contraceptives 369 383 3754 3768 I-contraception_consent
are 384 387 3769 3772 O
also 388 392 3773 3777 O
used 393 397 3778 3782 O
. 397 398 3782 3783 O
All 399 402 3784 3787 O
subjects 403 411 3788 3796 O
of 412 414 3797 3799 O
reproductive 415 427 3800 3812 O
potential 428 437 3813 3822 O
must 438 442 3823 3827 O
agree 443 448 3828 3833 B-contraception_consent
to 449 451 3834 3836 I-contraception_consent
use 452 455 3837 3840 I-contraception_consent
both 456 460 3841 3845 I-contraception_consent
a 461 462 3846 3847 I-contraception_consent
barrier 463 470 3848 3855 I-contraception_consent
method 471 477 3856 3862 I-contraception_consent
and 478 481 3863 3866 I-contraception_consent
a 482 483 3867 3868 I-contraception_consent
second 484 490 3869 3875 I-contraception_consent
method 491 497 3876 3882 I-contraception_consent
of 498 500 3883 3885 I-contraception_consent
birth 501 506 3886 3891 I-contraception_consent
control 507 514 3892 3899 I-contraception_consent
. 514 515 3899 3900 O
Women 516 521 3901 3906 B-gender
of 522 524 3907 3909 O
childbearing 525 537 3910 3922 O
potential 538 547 3923 3932 O
must 548 552 3933 3937 O
have 553 557 3938 3942 O
a 558 559 3943 3944 O
negative 560 568 3945 3953 B-pregnancy
pregnancy 569 578 3954 3963 I-pregnancy
test 579 583 3964 3968 O
at 584 586 3969 3971 O
screening 587 596 3972 3981 O

The 0 3 3982 3985 O
subject 4 11 3986 3993 O
is 12 14 3994 3996 O
unable 15 21 3997 4003 O
to 22 24 4004 4006 O
swallow 25 32 4007 4014 O
tablets 33 40 4015 4022 B-treatment

The 0 3 4023 4026 O
subject 4 11 4027 4034 O
is 12 14 4035 4037 O
≥ 15 16 4038 4039 O
18 17 19 4040 4042 B-lower_bound
years 20 25 4043 4048 I-lower_bound
old 26 29 4049 4052 O
on 30 32 4053 4055 O
the 33 36 4056 4059 O
day 37 40 4060 4063 O
of 41 43 4064 4066 O
consent 44 51 4067 4074 O

The 0 3 4075 4078 O
subject 4 11 4079 4086 O
requires 12 20 4087 4095 O
concomitant 21 32 4096 4107 B-treatment
treatment 33 42 4108 4117 I-treatment
, 42 43 4117 4118 O
in 44 46 4119 4121 O
therapeutic 47 58 4122 4133 O
doses 59 64 4134 4139 O
, 64 65 4139 4140 O
unless 66 72 4141 4147 O
deemed 73 79 4148 4154 O
clinically 80 90 4155 4165 O
unsafe 91 97 4166 4172 O
to 98 100 4173 4175 O
discontinue 101 112 4176 4187 O
, 112 113 4187 4188 O
with 114 118 4189 4193 O
anticoagulants 119 133 4194 4208 B-treatment
such 134 138 4209 4213 O
as 139 141 4214 4216 O
warfarin 142 150 4217 4225 B-treatment
or 151 153 4226 4228 O
warfarin 154 162 4229 4237 B-treatment
- 162 163 4237 4238 I-treatment
related 163 170 4238 4245 I-treatment
agents 171 177 4246 4252 I-treatment
, 177 178 4252 4253 O
unfractionated 179 193 4254 4268 O
heparin 194 201 4269 4276 B-treatment
, 201 202 4276 4277 O
thrombin 203 211 4278 4286 B-treatment
or 212 214 4287 4289 O
Factor 215 221 4290 4296 B-treatment
Xa 222 224 4297 4299 I-treatment
inhibitors 225 235 4300 4310 I-treatment
, 235 236 4310 4311 O
or 237 239 4312 4314 O
antiplatelet 240 252 4315 4327 B-treatment
agents 253 259 4328 4334 I-treatment
( 260 261 4335 4336 O
eg 261 263 4336 4338 O
, 263 264 4338 4339 O
clopidogrel 265 276 4340 4351 B-treatment
) 276 277 4351 4352 O
. 277 278 4352 4353 O
Low 279 282 4354 4357 B-treatment
dose 283 287 4358 4362 I-treatment
aspirin 288 295 4363 4370 I-treatment
( 296 297 4371 4372 O
≤ 297 298 4372 4373 O
100 299 302 4374 4377 B-upper_bound
mg 303 305 4378 4380 I-upper_bound
/ 305 306 4380 4381 O
day 306 309 4381 4384 O
) 309 310 4384 4385 O
, 310 311 4385 4386 O
low 312 315 4387 4390 B-treatment
- 315 316 4390 4391 I-treatment
dose 316 320 4391 4395 I-treatment
warfarin 321 329 4396 4404 I-treatment
( 330 331 4405 4406 O
≤ 331 332 4406 4407 O
1 333 334 4408 4409 B-upper_bound
mg 335 337 4410 4412 I-upper_bound
/ 337 338 4412 4413 O
day 338 341 4413 4416 O
) 341 342 4416 4417 O
are 343 346 4418 4421 O
permitted 347 356 4422 4431 O
. 356 357 4431 4432 O
Both 358 362 4433 4437 O
prophylactic 363 375 4438 4450 B-treatment
and/or 376 382 4451 4457 O
treatment 383 392 4458 4467 B-treatment
dose 393 397 4468 4472 I-treatment
low 398 401 4473 4476 I-treatment
molecular 402 411 4477 4486 I-treatment
weight 412 418 4487 4493 I-treatment
( 419 420 4494 4495 I-treatment
fractionated 420 432 4495 4507 I-treatment
) 432 433 4507 4508 I-treatment
heparin 434 441 4509 4516 I-treatment
( 442 443 4517 4518 I-treatment
LMWH 443 447 4518 4522 I-treatment
) 447 448 4522 4523 I-treatment
are 449 452 4524 4527 O
permitted 453 462 4528 4537 O
and 463 466 4538 4541 O
are 467 470 4542 4545 O
the 471 474 4546 4549 O
preferred 475 484 4550 4559 O
agents 485 491 4560 4566 O
to 492 494 4567 4569 O
administer 495 505 4570 4580 O

Uncontrolled 0 12 4581 4593 B-cancer
concurrent 13 23 4594 4604 I-cancer
malignancy 24 34 4605 4615 I-cancer
that 35 39 4616 4620 O
would 40 45 4621 4626 O
limit 46 51 4627 4632 O
assessment 52 62 4633 4643 O
of 63 65 4644 4646 O
efficacy 66 74 4647 4655 O
of 75 77 4656 4658 O
cabozantinib 78 90 4659 4671 B-treatment

Urine 0 5 4672 4677 B-clinical_variable
protein 6 13 4678 4685 I-clinical_variable
/ 13 14 4685 4686 I-clinical_variable
creatinine 14 24 4686 4696 I-clinical_variable
ratio 25 30 4697 4702 I-clinical_variable
( 31 32 4703 4704 I-clinical_variable
UPCR 32 36 4704 4708 I-clinical_variable
) 36 37 4708 4709 I-clinical_variable
≤ 38 39 4710 4711 O
1 40 41 4712 4713 B-upper_bound
mg 42 44 4714 4716 I-upper_bound
/ 44 45 4716 4717 I-upper_bound
mg 45 47 4717 4719 I-upper_bound
( 48 49 4720 4721 I-upper_bound
113.2 49 54 4721 4726 I-upper_bound
mg 55 57 4727 4729 I-upper_bound
/ 57 58 4729 4730 I-upper_bound
mmol 58 62 4730 4734 I-upper_bound
) 62 63 4734 4735 I-upper_bound
creatinine 64 74 4736 4746 O
or 75 77 4747 4749 O
24 78 80 4750 4752 B-clinical_variable
- 80 81 4752 4753 I-clinical_variable
hr 81 83 4753 4755 I-clinical_variable
urine 84 89 4756 4761 I-clinical_variable
protein 90 97 4762 4769 I-clinical_variable
of 98 100 4770 4772 O
< 101 102 4773 4774 O
1 103 104 4775 4776 B-upper_bound
g 105 106 4777 4778 I-upper_bound

Women 0 5 4779 4784 B-gender
of 6 8 4785 4787 O
childbearing 9 21 4788 4800 O
potential 22 31 4801 4810 O
include 32 39 4811 4818 O
women 40 45 4819 4824 B-gender
who 46 49 4825 4828 O
have 50 54 4829 4833 O
experienced 55 66 4834 4845 O
menarche 67 75 4846 4854 O
and 76 79 4855 4858 O
who 80 83 4859 4862 O
have 84 88 4863 4867 O
not 89 92 4868 4871 O
undergone 93 102 4872 4881 O
successful 103 113 4882 4892 O
surgical 114 122 4893 4901 B-treatment
sterilization 123 136 4902 4915 I-treatment
( 137 138 4916 4917 O
hysterectomy 138 150 4917 4929 B-treatment
, 150 151 4929 4930 O
bilateral 152 161 4931 4940 B-treatment
tubal 162 167 4941 4946 I-treatment
ligation 168 176 4947 4955 I-treatment
, 176 177 4955 4956 O
or 178 180 4957 4959 O
bilateral 181 190 4960 4969 B-treatment
oophorectomy 191 203 4970 4982 I-treatment
) 203 204 4982 4983 O
or 205 207 4984 4986 O
are 208 211 4987 4990 O
not 212 215 4991 4994 O
postmenopausal 216 230 4995 5009 O

active 0 6 5010 5016 B-chronic_disease
infection 7 16 5017 5026 I-chronic_disease
requiring 17 26 5027 5036 O
systemic 27 35 5037 5045 B-treatment
treatment 36 45 5046 5055 I-treatment
within 46 52 5056 5062 O
28 53 55 5063 5065 B-upper_bound
days 56 60 5066 5070 I-upper_bound
before 61 67 5071 5077 O
the 68 71 5078 5081 O
first 72 77 5082 5087 O
dose 78 82 5088 5092 O
of 83 85 5093 5095 O
study 86 91 5096 5101 B-treatment
treatment 92 101 5102 5111 I-treatment

active 0 6 5112 5118 O
peptic 7 13 5119 5125 B-chronic_disease
ulcer 14 19 5126 5131 I-chronic_disease
disease 20 27 5132 5139 I-chronic_disease

bowel 0 5 5140 5145 B-chronic_disease
obstruction 6 17 5146 5157 I-chronic_disease
or 18 20 5158 5160 O
gastric 21 28 5161 5168 B-chronic_disease
outlet 29 35 5169 5175 I-chronic_disease
obstruction 36 47 5176 5187 I-chronic_disease

clinically 0 10 5188 5198 O
- 10 11 5198 5199 O
significant 11 22 5199 5210 O
cardiac 23 30 5211 5218 B-chronic_disease
arrhythmias 31 42 5219 5230 I-chronic_disease

clinically 0 10 5231 5241 O
- 10 11 5241 5242 O
significant 11 22 5242 5253 O
hematemesis 23 34 5254 5265 B-chronic_disease
or 35 37 5266 5268 O
gastrointestinal 38 54 5269 5285 B-chronic_disease
bleeding 55 63 5286 5294 I-chronic_disease

concurrent 0 10 5295 5305 O
uncompensated 11 24 5306 5319 O
hypothyroidism 25 39 5320 5334 B-chronic_disease
or 40 42 5335 5337 O
thyroid 43 50 5338 5345 B-chronic_disease
dysfunction 51 62 5346 5357 I-chronic_disease
within 63 69 5358 5364 O
7 70 71 5365 5366 B-upper_bound
days 72 76 5367 5371 I-upper_bound
before 77 83 5372 5378 I-upper_bound
the 84 87 5379 5382 O
first 88 93 5383 5388 O
dose 94 98 5389 5393 O
of 99 101 5394 5396 O
study 102 107 5397 5402 O
treatment 108 117 5403 5412 B-treatment

gastrointestinal 0 16 5413 5429 B-chronic_disease
perforation 17 28 5430 5441 I-chronic_disease

history 0 7 5442 5449 O
of 8 10 5450 5452 O
abdominal 11 20 5453 5462 B-chronic_disease
fistula 21 28 5463 5470 I-chronic_disease

history 0 7 5471 5478 O
of 8 10 5479 5481 O
organ 11 16 5482 5487 B-treatment
transplant 17 27 5488 5498 I-treatment

inflammatory 0 12 5499 5511 B-chronic_disease
bowel 13 18 5512 5517 I-chronic_disease
disease 19 26 5518 5525 I-chronic_disease
( 27 28 5526 5527 O
including 28 37 5527 5536 O
ulcerative 38 48 5537 5547 B-chronic_disease
colitis 49 56 5548 5555 I-chronic_disease
and 57 60 5556 5559 O
Crohn 61 66 5560 5565 B-chronic_disease
's 66 68 5565 5567 I-chronic_disease
disease 69 76 5568 5575 I-chronic_disease
) 76 77 5575 5576 O
, 77 78 5576 5577 O
diverticulitis 79 93 5578 5592 B-chronic_disease
, 93 94 5592 5593 O
cholecystitis 95 108 5594 5607 B-chronic_disease
, 108 109 5607 5608 O
symptomatic 110 121 5609 5620 O
cholangitis 122 133 5621 5632 B-chronic_disease
or 134 136 5633 5635 O
appendicitis 137 149 5636 5648 B-chronic_disease

intra 0 5 5649 5654 B-chronic_disease
- 5 6 5654 5655 I-chronic_disease
abdominal 6 15 5655 5664 I-chronic_disease
abscess 16 23 5665 5672 I-chronic_disease

intra 0 5 5673 5678 B-cancer
- 5 6 5678 5679 I-cancer
abdominal 6 15 5679 5688 I-cancer
tumor 16 21 5689 5694 I-cancer
/ 21 22 5694 5695 I-cancer
metastases 22 32 5695 5705 I-cancer
invading 33 41 5706 5714 O
GI 42 44 5715 5717 O
mucosa 45 51 5718 5724 O
( 52 53 5725 5726 O
malignant 53 62 5726 5735 B-cancer
abdominal 63 72 5736 5745 I-cancer
ascites 73 80 5746 5753 I-cancer
does 81 85 5754 5758 O
not 86 89 5759 5762 O
constitute 90 100 5763 5773 O
mucosal 101 108 5774 5781 O
invasion 109 117 5782 5790 O
) 117 118 5790 5791 O

malabsorption 0 13 5792 5805 B-chronic_disease
syndrome 14 22 5806 5814 I-chronic_disease

pregnant 0 8 5815 5823 B-pregnancy

serious 0 7 5824 5831 O
non 8 11 5832 5835 O
- 11 12 5835 5836 O
healing 12 19 5836 5843 O
wound 20 25 5844 5849 O
/ 25 26 5849 5850 O
ulcer 26 31 5850 5855 B-chronic_disease
/ 31 32 5855 5856 O
bone 32 36 5856 5860 O
fracture 37 45 5861 5869 O
within 46 52 5870 5876 O
28 53 55 5877 5879 B-upper_bound
days 56 60 5880 5884 I-upper_bound
before 61 67 5885 5891 I-upper_bound
the 68 71 5892 5895 O
first 72 77 5896 5901 O
dose 78 82 5902 5906 O
of 83 85 5907 5909 O
study 86 91 5910 5915 B-treatment
treatment 92 101 5916 5925 I-treatment

stroke 0 6 5926 5932 B-chronic_disease
( 7 8 5933 5934 O
including 8 17 5934 5943 O
TIA 18 21 5944 5947 B-chronic_disease
, 21 22 5947 5948 O
or 23 25 5949 5951 O
other 26 31 5952 5957 O
ischemic 32 40 5958 5966 B-chronic_disease
event 41 46 5967 5972 O
) 46 47 5972 5973 O
myocardial 48 58 5974 5984 B-chronic_disease
infarction 59 69 5985 5995 I-chronic_disease

thromboembolic 0 14 5996 6010 B-chronic_disease
event 15 20 6011 6016 I-chronic_disease
requiring 21 30 6017 6026 O
therapeutic 31 42 6027 6038 B-treatment
anticoagulation 43 58 6039 6054 I-treatment
except 59 65 6055 6061 O
if 66 68 6062 6064 O
anticoagulation 69 84 6065 6080 O
is 85 87 6081 6083 O
as 88 90 6084 6086 O
stipulated 91 101 6087 6097 O
in 102 104 6098 6100 O
Exclusion 105 114 6101 6110 O
Criterium 115 124 6111 6120 O
# 125 126 6121 6122 O
6 126 127 6122 6123 O

unstable 0 8 6124 6132 O
angina 9 15 6133 6139 B-chronic_disease
pectoris 16 24 6140 6148 I-chronic_disease

≤ 0 1 6149 6150 O
3.0 2 5 6151 6154 B-upper_bound
× 6 7 6155 6156 I-upper_bound
ULN 8 11 6157 6160 I-upper_bound
if 12 14 6161 6163 O
no 15 17 6164 6166 O
liver 18 23 6167 6172 O
involvement 24 35 6173 6184 O
, 35 36 6184 6185 O
or 37 39 6186 6188 O
≤ 40 41 6189 6190 O
5 42 43 6191 6192 B-upper_bound
× 44 45 6193 6194 I-upper_bound
ULN 46 49 6195 6198 I-upper_bound
with 50 54 6199 6203 O
liver 55 60 6204 6209 O
involvement 61 72 6210 6221 O

